DV
Dividend Vision

BJDX Stock — Bluejay Diagnostics Inc

Bluejay Diagnostics Inc (BJDX)

Updated November 9, 2026.

BJDX is a stock. Total return is -100.0% over the past 5 years, 173.6 points behind SPY at 73.6%.

Bluejay Diagnostics is a medical diagnostics company that develops and markets the Symphony technology platform, which includes an analyzer and single-use cartridges designed to measure diagnostic biomarkers in blood samples for critical care and other clinical applications. The company does not currently have an established distribution schedule. This security may appeal to investors seeking exposure to the healthcare diagnostics sector, though potential investors should note the company's early-stage status and lack of current dividend income.

BJDX dividend yield and income

Price as of 2026-11-09.

The dividend amount is $0.0975.

1 recorded distributions
Ex-dateAmountChange from previous payment
2023-07-24$0.0975—
2023 total$0.0975—

BJDX performance versus SPY

Total return is -100.0% over the past 5 years, 173.6 points behind SPY at 73.6%. Over the past year its total return — price change plus distributions reinvested — is -90.1%. Its deepest 1-year drawdown was 92.3%.

WindowTotal returnCAGR
1M-24.4%—
3M-41.8%—
6M-63.8%—
YTD-76.7%—
1Y-90.1%—
2Y CAGR—-81.50%
3Y CAGR—-95.00%
Since inception 2021-11-10 · 5 years-100.0%-91.80%

BJDX key facts

Asset type
Stock
Asset class
Equity
Inception date
11/10/2021
Distribution frequency
None
Last close
$2.49 (as of 2026-11-09)
Market cap
$11,125,447
Average volume
32,660
Dividend
$0.0975
Beta
0.923
Payout ratio
0.0%
EPS
-$14.32

How Dividend Vision calculates returns

Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BJDX risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 92.3%.

Who may consider BJDX — and who may not

It is a weaker fit for investors who need monthly cash flow (BJDX does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BJDX

Tagged: Healthcare.

Frequently asked questions

Does BJDX pay monthly?

No. BJDX does not currently distribute.

When does BJDX pay a dividend?

BJDX does not currently distribute. The dividend amount is $0.0975.

How has BJDX performed?

Total return is -100.0% over the past 5 years, 173.6 points behind SPY at 73.6%. Over the past year its total return — price change plus distributions reinvested — is -90.1%. Its deepest 1-year drawdown was 92.3%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.